rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1986-11-20
|
pubmed:abstractText |
The functional significance of the reported affinity of (+)-3-PPP and (+)-N-allylnormetazocine (NANM) for the same binding site in rat brain membranes was assessed by studying (+)-3-PPP as a agonist and antagonist of (+)-NANM in rats trained to discriminate 5.0 mg/kg (+)-NANM from saline. Over a wide dose range, (+)-3-PPP was able to block the discriminative stimulus effects of (+)-NANM, with complete antagonism at 1.0 mg/kg i.p. Since (+)-NANM is a prototype sigma-opioid agonist, (+)-3-PPP is a good candidate for being a competitive sigma antagonist.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-2999
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
283-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3019734-Animals,
pubmed-meshheading:3019734-Binding Sites,
pubmed-meshheading:3019734-Conditioning, Operant,
pubmed-meshheading:3019734-Discrimination (Psychology),
pubmed-meshheading:3019734-Generalization, Stimulus,
pubmed-meshheading:3019734-Phenazocine,
pubmed-meshheading:3019734-Piperidines,
pubmed-meshheading:3019734-Rats,
pubmed-meshheading:3019734-Rats, Inbred Strains,
pubmed-meshheading:3019734-Receptors, Opioid,
pubmed-meshheading:3019734-Receptors, Opioid, delta
|
pubmed:year |
1986
|
pubmed:articleTitle |
(+)-3-PPP antagonizes the discriminative stimulus effects of (+)-N-allylnormetazocine.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|